Comparative study of assays for prostate-specific antigen molecular forms

Japanese Journal of Clinical Oncology

Volumn 29, Issue 6, 1999, Pages 303-307

  Kuriyama, Manabu ^a   Uno, Hiromi ^a   Ueno, Kazuya ^a   Hamamoto, Yukihiro ^a   Vihn, Pharm Quang ^a   Ban, Yoshihito ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Prostate cancer; Prostate specific antigen; PSA molecular forms; Standardization diagnostic gray zone

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE INHIBITOR;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; HUMAN; MALE; PROSTATE TUMOR; STATISTICAL MODEL;

ALPHA 1-ANTICHYMOTRYPSIN; HUMANS; LINEAR MODELS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REAGENT KITS, DIAGNOSTIC; SERINE PROTEINASE INHIBITORS;

EID: 0033145169     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.6.303     Document Type: Review

References (21)

1. Kuriyama M. Prostate-specific antigen as a tumor marker in prostate cancer. Int J Urol 1994;145:99-113.
2. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, et al. Evaluation of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J Am Med Assoc 1995;274:1214-20.
3. Luderer AA, Chen Y-T, Soriano TF, Kramp WJ, Carlson G, Cuny C, et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995;46:187-94.
4. Froschermaier SE, Pilarsky CP, Wirth MP. Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma. Urology 1996;47:525-8.
5. Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, et al. Significance of serum free prostate specific antigen in the screening of prostate cancer. J Urol 1996;156:1964-8.
6. Kuriyama M, Kawada Y, Arai Y, Maeda H, Egawa S, Koshiba K, et al. Significance of free to total PSA ratio in men with slightly elevated serum PSA levels: a cooperative study. Jpn J Clin Oncol 1998;28:661-5.
7. Kano S, Ito Y, Ishibashi M, Kuriyama M, Ito T. The present status and discrepancy of serum total PSA value between 28 assay systems commercially available in Japan - Subcommittee report of first study on serum total PSA assays. Hinyoki Geka 1998;11:942-9 (in Japanese).
8. 1-antichymotrypsin-complexed PSA and free/total PSA ratio using the specific and sensitive enzyme-linked immunosorbent assay 'E-plate EIKEN PSA'. Hinyokika Kiyo 1998;44:755-63 (in Japanese).
9. Kuriyama M, Takeuchi T, Shinoda I, Okano M, Nishiura T. Clinical evaluation of γ-seminoprotein in prostate cancer. Prostate 1987;8:301-3.
10. Demura T, Shinohara N, Tanaka M, Enami N, Chiba H, Togashi M, et al. The proportion of free to total prostate specific antigen. Cancer 1996;77:1137-43.
11. 1-antichymotrypsin determination in prostate cancer. Hinyoki Geka 1995;8:951-8 (in Japanese).
12. 1-antichymotrypsin complex value in diagnosis of prostate cancer. Int J Urol 1998;5:48-54.
13. Allard WJ, Zhou Z, Yeung KK. Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. Clin Chem 1998;44:1216-23.
14. Brawer MK, Meyer GT, Letra JL, Bankson DD, Morris DL, Yeung KK, et al. Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology 1998;52:372-8.
15. Kuriyama M. The evaluation of PSA molecular forms, molecular ratio and PSAD in the cases showing slightly elevated serum PSA values for screening prostate cancer. Hinyoki Geka 1998;11:925-30 (in Japanese).
16. Abrahamsson PA, Kuriyama M. Molecular forms of serum prostate-specific antigen: the clinical usefulness of percent free PSA to discriminate prostate cancer from BPH. Acta Urol Jpn 1998;44:223-32.
17. Benson MC, Whang IS, Pantunck AP, Ring K, Kaplam S A, Olsson CA, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-6.
18. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a community-based population of healthy men; establishment of age-specific reference ranges. J Am Med Assoc 1993;270:860-4.
19. Smith DS, Catalona WJ, Herschman JD. Longitudinal screening for prostate cancer with prostate-specific antigen. J Am Med Assoc 1996;276:1309-15.
20. Wu JT. Assay for prostate specific antigen (PSA): problems and possible solution. J Clin Lab Anal 1994;8:51-62.
21. Kuriyama M. Unpublished data.